Neurology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal/Neuropsychology Unit, Centro Hospitalar Universitário do Porto, Porto, Portugal.
Neurology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.
Mult Scler. 2022 Aug;28(9):1382-1391. doi: 10.1177/13524585211066598. Epub 2021 Dec 30.
Cognitive dysfunction as a predictor of clinical progression and mortality in multiple sclerosis (MS) is still a matter of debate.
The aim of this study was to explore the long-term outcome associated with neuropsychological performance in a cohort of patients with MS.
A series of 408 MS patients had previously undergone a comprehensive neuropsychological assessment and a contemporaneous neurological evaluation (T1). A retrospective review of the clinical records was conducted 102-192 months after T1. Demographic and clinical data regarding the last clinical appointment with EDSS measurement (T2) were collected and the date of the last clinical contact or death (TS) was recorded.
This review revealed that cognitive dysfunction (T1) was associated with higher odds of transitioning from relapsing-remitting course to a progressive disease course (adjusted odds ratio (OR) = 2.29, = 0.043) and higher hazard of death in the total sample (adjusted hazard ratio (HR) = 3.07, = 0.006) and the progressive disease course subgroup (adjusted HR = 3.68, = 0.007), even when adjusting for other covariates.
The study results demonstrate that cognitive dysfunction in MS is predictive of poorer prognosis and mortality.
认知功能障碍作为多发性硬化症(MS)临床进展和死亡率的预测因素仍存在争议。
本研究旨在探讨认知神经心理学表现与 MS 患者长期预后的相关性。
先前对 408 例 MS 患者进行了全面的神经心理学评估和同期神经学评估(T1)。回顾性分析 T1 后 102-192 个月的临床记录。收集最后一次 EDSS 测量时的人口统计学和临床数据(T2),并记录最后一次临床就诊或死亡的日期(TS)。
本研究发现,认知功能障碍(T1)与从缓解复发型病程向进展型病程转变的可能性增加相关(调整后的优势比(OR)=2.29,=0.043),并且在总样本(调整后的危险比(HR)=3.07,=0.006)和进展型疾病组亚组(调整后的 HR=3.68,=0.007)中,认知功能障碍与死亡风险增加相关,即使调整了其他协变量。
研究结果表明,MS 中的认知功能障碍与预后不良和死亡率相关。